New statin guidelines would put half of U.S. adults on drugs
Guidelines have been criticized for overreach by suggesting medications such as Zocor and Lipitor for such a broad swath of U.S. population (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 19, 2014 Category: Consumer Health News Source Type: news
How a daily statin tablet could slow march of MS
Previous research using simvastatin in people with early-stage MS found reductions in brain lesions, suggesting the statin was affecting the disease process. (Source: the Mail online | Health)
Source: the Mail online | Health - March 19, 2014 Category: Consumer Health News Source Type: news
Statins slow the progression of advanced multiple sclerosis in clinical trial
Statins may provide doctors with an unlikely new weapon with which to slow the progression of multiple sclerosis (MS).No treatments can currently abate the advanced stage of the disease, known as secondary progressive MS, which gradually causes patients to become more disabled. In a two-year clinical trial involving 140 patients with secondary progressive MS, the drug simvastatin slowed brain shrinkage, which is thought to contribute to patients' impairments. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 19, 2014 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news
Multiple sclerosis patients may benefit from statins, says study
This study suggests, however, that the beneficial effect might be on vascular function rather than the immune system, he added. "After nearly two decades of research, it is immensely gratifying to see this work progress into the clinic to deliver benefits to patients," he said.MS is an autoimmune disease in which myelin, the fatty insulating material that covers nerve fibres, is destroyed by the body's own defences. Nerves lacking myelin are not able to transmit messages properly, leading to symptoms ranging from mild tingling or numbness to full blown paralysis.Dr Susan Kohlhaas, head of biomedical research at the MS Soci...
Source: Guardian Unlimited Science - March 19, 2014 Category: Science Authors: Sarah Boseley Tags: The Guardian Pharmaceuticals industry News UCL (University College London) Health Medical research Society Drugs Multiple sclerosis UK news Science Source Type: news
Small trial of simvastatin shows promise as treatment for MS
Brain volume loss and progression of the condition were both slowed and quality of life was improved (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - March 19, 2014 Category: Neurology Source Type: news
Statins may slow progression of MS
ConclusionThis was an early stage, phase II trial, which found that simvastatin reduced the rate of brain shrinkage in patients in the later stages of MS. The results are promising and warrant a larger phase III trial, examining whether the drug could slow the disease in patients at this stage of MS. It should be noted that although simvastatin had some effect on outcomes in one disability scale and one symptom scale, the trial was primarily aimed at measuring the effect on brain shrinkage, rather than patients’ symptoms.To conclude, it is unclear what effect simvastatin, if any, would have on long-term quality of life...
Source: NHS News Feed - March 19, 2014 Category: Consumer Health News Tags: Medication Neurology Source Type: news
NICE publishes new draft guidelines on statins use
"Millions more people should be put on cholesterol-lowering statin drugs," BBC News reports. Draft guidance from the National Institute for Health and Care Excellence (NICE) has recommended that the drugs should be given to people with an estimated 1 in 10 or more risk of cardiovascular disease (CVD), which includes conditions such as heart disease and stroke.
Statins are medicines that can help lower rates of low-density lipoprotein (LDL) cholesterol (so-called "bad" cholesterol) in the blood. High rates of LDL cholesterol can lead to hardening of the arteries, a risk factor for CVDs.
At present,...
Source: NHS News Feed - February 12, 2014 Category: Consumer Health News Tags: Heart/lungs Medication QA articles Source Type: news
McSweeney / Langevin Announces it is Providing Legal Advice to Woman...
The law firm McSweeney / Langevin is investigating legal claims on behalf of woman allegedly harmed by cholesterol lowering drugs Lipitor, Zocor and Crestor. The investigation follows the Food and...(PRWeb November 18, 2013)Read the full story at http://www.prweb.com/releases/2013/11/prweb11335102.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 19, 2013 Category: Pharmaceuticals Source Type: news
Assessing the Effect of Simvastatin in PBCAssessing the Effect of Simvastatin in PBC
Is simvastatin an effective drug therapy in the treatment of primary biliary cirrhosis? Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 14, 2013 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Statin Fails in ICU Pneumonia Trial Statin Fails in ICU Pneumonia Trial
Adjunctive simvastatin therapy fails to boost survival in ventilator-associated pneumonia. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 14, 2013 Category: Consumer Health News Tags: Critical Care News Source Type: news
McSweeney / Langevin Providing Legal Advice in Response to Alleged...
The law firm McSweeney / Langevin is investigating Type 2 Diabetes claims allegedly caused by the cholesterol-lowering drugs Lipitor, Zocor, and Crestor. McSweeney / Langevin's legal investigation...(PRWeb October 11, 2013)Read the full story at http://www.prweb.com/releases/2013/10/prweb11218941.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 14, 2013 Category: Pharmaceuticals Source Type: news
Injury Law Firm Releases New Information Graphic about Alleged Kidney...
d’Oliveira & Associates has posted a new infographic which provides a list of side effects and timeline of events. The law firm works with some of the more experienced Zocor lawyers who handle...(PRWeb October 04, 2013)Read the full story at http://www.prweb.com/releases/2013/10/prweb11155538.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 5, 2013 Category: Pharmaceuticals Source Type: news
Simvastatin Cuts Heparin-Binding Protein in Acute Lung InjurySimvastatin Cuts Heparin-Binding Protein in Acute Lung Injury
Does oral administration of simvastatin in patients with acute lung injury improves ICU outcomes -- simply by reducing heparin-binding protein? BMC Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 4, 2013 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news
Statin use linked to small increase in cataracts risk
Conclusion
This research using a large cohort of people from a military healthcare system finds that overall, use of statins for over 90 days was associated with a slight increase in a person’s risk of developing cataracts.
Further analyses suggested that the risk was higher among people who did not have any additional diseases.
From this the researchers suggest that risk may be higher when statins are given for what is called primary prevention, i.e. given to people with risk factors for cardiovascular disease but who have not yet suffered any cardiovascular disease events such as a heart attack or stroke.
The study h...
Source: NHS News Feed - September 20, 2013 Category: Consumer Health News Tags: Medication Older people Heart/lungs Source Type: news
Juvisync (Sitagliptin and Simvastatin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 28, 2013 Category: Drugs & Pharmacology Source Type: news
